Detail Information

Publications69

David A FiellinDepartment of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut, USAJ Stud Alcohol Drugs 74:500-4. 2013

..Daily estimation measures such as the Timeline Followback (TLFB) have been validated, yet the optimal time window and its performance in non-treatment-seeking medical clinic subjects and among those with HIV are not known...

..Chart audits and mentoring should be considered as a mechanism to foster quality care. These processes of care are likely to require attention for treatment using methadone or buprenorphine...

Consensus statement on office-based treatment of opioid dependence using buprenorphine

David A FiellinDepartment of Internal Medicine, Yale University School of Medicine, New Haven, CT, USAJ Subst Abuse Treat 27:153-9. 2004

....

Opioid dependence: rationale for and efficacy of existing and new treatments

David A FiellinYale University School of Medicine, New Haven, CT 06520 8025, USAClin Infect Dis 43:S173-7. 2006

..This review focuses on the neurobiological basis of opioid dependence, the rationale for methadone and buprenorphine treatments, and issues in prescribing these medications to patients with HIV infection...

David A FiellinDepartment of Internal Medicine, Yale University School of Medicine, New Haven, Conn 06520, USAN Engl J Med 355:365-74. 2006

..The optimal level of counseling and frequency of attendance for medication distribution has not been established for the primary care, office-based buprenorphine-naloxone treatment of opioid dependence...

..We conclude that providing clinic-based methadone is least expensive. The price of buprenorphine accounts for a major portion of the difference in costs. For patients, office-based treatment may be less expensive...

Faculty development in small-group teaching skills associated with a training course on office-based treatment of opioid dependence

..Behaviors associated with opioid dependence often involve criminal activity, which can lead to incarceration. The impact of a history of incarceration on outcomes in primary care office-based buprenorphine/naloxone is not known...

Non-medical use, abuse and dependence on sedatives and tranquilizers among U.S. adults: psychiatric and socio-demographic correlates

William C BeckerDepartment of Internal Medicine, Yale University School of Medicine, New Haven, CT 06520 8025, United StatesDrug Alcohol Depend 90:280-7. 2007

..Non-medical use of sedatives and tranquilizers carries risks including development of abuse/dependence. Such use may correlate with psychiatric symptoms...

..Gender differences exist regarding alcohol and illicit drug use disorders in the United States. Little is known about the gender-related factors associated with non-medical use of prescription opioids...

Non-medical use, abuse and dependence on prescription opioids among U.S. adults: psychiatric, medical and substance use correlates

William C BeckerDepartment of Internal Medicine, Yale University School of Medicine, New Haven, CT 06520 8025, United StatesDrug Alcohol Depend 94:38-47. 2008

..Non-medical use of prescription opioids carries risks including development of abuse/dependence. Such use may correlate with psychiatric, medical, and substance use characteristics...

The association between cocaine use and treatment outcomes in patients receiving office-based buprenorphine/naloxone for the treatment of opioid dependence

..35%, p = .001). We conclude that both baseline and in-treatment cocaine use is associated with worse treatment outcomes in patients receiving office-based buprenorphine/naloxone and may benefit from targeted interventions...

..Despite the availability and demonstrated effectiveness of office-based buprenorphine maintenance treatment (BMT), the systematic examination of physicians' attitudes towards this new medical practice has been largely neglected...

Brief intervention for hazardous and harmful drinkers in the emergency department

..This opportunity has a three-year window, however, and a critical need will be to attract a sufficient number of physicians into prescribing buprenorphine/naloxone in order to allow our patients increased access to this treatment...

Decreasing international HIV transmission: the role of expanding access to opioid agonist therapies for injection drug users

..In addition, the literature focuses almost exclusively on patients with alcohol abuse or dependence in psychiatric inpatient settings, and excludes patients with less severe alcohol problems and primary care outpatient settings...

The practice of office-based buprenorphine treatment of opioid dependence: is it associated with new patients entering into treatment?

A randomized trial of primary intensive care to reduce hospital admissions in patients with high utilization of inpatient services

William H SledgeDepartment of Psychiatry, Yale University School of Medicine, Yale New Haven Psychiatric Hospital, New Haven, Connecticut 06519, USADis Manag 9:328-38. 2006

..We were unable to detect a difference in hospital use or functional status, mental health function, or medication adherence among patients who require frequent hospital admissions using our intervention...

..3% were brought back attached to the skin) and that weekly sweat testing is less sensitive than weekly urine testing in detecting opiate use, suggest limited utility of sweat patch testing in outpatient clinical settings...